TAMPA, Fla., Aug. 5, 2010 (GLOBE NEWSWIRE) -- SRI/Surgical Express, Inc. (SRI) (Nasdaq:STRC), a leading provider of reusable surgical products and reprocessing services supporting the healthcare industry, today announced it has engaged the investor relations firm SM Berger & Company. Founded in 1984, SM Berger & Company has helped over 100 companies develop and execute investor relations programs. Located in Cleveland, Ohio, their clients include large and small companies, and span multiple markets.
Gerald Woodard, SRI's Chief Executive Officer, said: "We are pleased to begin this relationship with Stanley and Andrew Berger. After speaking with several firms, we believe that SM Berger & Company is the best fit for SRI Surgical. We look forward to beginning the process of increased communications to our shareholders and the financial community."
SM Berger & Company will work with SRI Surgical's management team to create and effectively communicate the company's business plan and financial model providing investors a clear and consistent message of management's vision.
About SRI Surgical
SRI Surgical (www.srisurgical.com) provides central processing and supply chain management services to hospitals and surgery centers across the United States. SRI Surgical serves hospitals and surgery centers in 25 states from 10 reprocessing facilities and four distribution centers located throughout the United States.
The SRI/Surgical Express, Inc. logo is available at http://www.globenewswire.com/newsroom/prs/?pkgid=4997
Forward-Looking Statements
The statements in this press release that are not historical, including statements regarding SRI Surgical's beliefs, expectations, and strategies, constitute "forward looking statements" within the meaning of the federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements. Important factors that could cause the differences are discussed in SRI Surgical's reports on Forms 10-Q, 10-K, and 8-K that the Company periodically files with the Securities and Exchange Commission. These factors include SRI Surgical's sales process and market acceptance of its products and services, SRI Surgical's capital needs, its dependence on significant customers and suppliers, risks of a new product offering, and the competitive healthcare marketplace. SRI Surgical does not undertake to update any forward-looking statements in this press release. Copies of SRI Surgical's SEC filings, including its annual report on Form 10-K and quarterly reports on Form 10-Q, may be obtained by contacting SRI Surgical's investor relations department at (813) 891-9550 or at the Investors section of the SRI Surgical Website at www.srisurgical.com.